CDRN
-
Study to explore optimal daily aspirin dose for heart health
The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease. Read MoreMay 21, 2015
-
Panel examines real-world role of pragmatic research trials
The question of what’s different about pragmatic research was aired in a well-attended panel discussion last week in Light Hall sponsored by the Vanderbilt Center for Health Services Research and the Mid-South Clinical Data Research Network (CDRN). Read MoreMar 12, 2015